Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-31 @ 12:14 AM
Study NCT ID:
NCT00004204
Status:
UNKNOWN
Last Update Posted:
2014-01-06
First Post:
2000-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor:
Herbert Irving Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000067449
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None